LabCorp and its Specialty Testing Group, a fully integrated portfolio of specialty and esoteric testing laboratories.
To monitor the phenobarbital level in your blood to ensure a therapeutic level while avoiding toxic side effects
At the start of therapy and at a regular intervals during treatment; when someone has signs and symptoms of toxicity or is experiencing seizures
A blood sample drawn from a vein in your arm
Phenobarbital is a long-acting barbiturate, an anti-epileptic drug (AED) and sedating drug that depresses the nervous system. Healthcare practitioners usually prescribe it to prevent seizures or to relieve anxiety. It is often prescribed to treat epilepsy and other seizure disorders because the drug stabilizes electrical activity in the brain. This test measures the phenobarbital level in the blood.
When you are being treated with phenobarbital, it is important to maintain a stable level of phenobarbital in the blood within the therapeutic range. If the level is too low, you may experience seizures or anxiety. If the level is too high, you could experience side effects or even toxicity. The toxic effects include drowsiness, confusion, and lack of voluntary coordination of muscle movement (ataxia), which can affect things like driving performance. If you are treated long-term, you may also develop tolerance to the sedative effects of the drug and become psychologically or physically dependent.
Maintaining a constant, therapeutic level of phenobarbital in the blood can be difficult. The gap between the level at which the drug is therapeutic and the level at which toxic side effects can occur is very small. This is called a narrow therapeutic index and is a primary reason the drug requires close monitoring.
Furthermore, phenobarbital is broken down (metabolized) by liver enzymes and eliminated in the urine at different rates, depending on your age and overall health. For different dose, age and health, elimination can take several days to weeks. Once the body has reached its maximum capacity to metabolize phenobarbital, even small increases in dose can result in large increases of the drug level in the blood. Side effects can become more severe and toxicity may occur.
Your healthcare provider will monitor your response to phenobarbital to make sure that the desired level of the drug is maintained in the blood and to determine the dose that works best for you. Your healthcare practitioner might order a phenobarbital level at the start of treatment and any time while you are on the medication to determine if the dose is right. The practitioner might also decide to order a test if you begin taking another medication because clinically significant drug interactions may occur.
This test is used to measure and monitor the amount of phenobarbital in the blood and to determine whether the drug level is within a therapeutic range. This test is used to ensure that the blood level of phenobarbital is not too low to cause a recurrence of seizures or too high to cause side effects. Depending on the result, your healthcare practitioner may adjust the drug dose up or down.
Your healthcare practitioner might decide to order a phenobarbital level if you begin taking another medication because drug interactions can affect how your body responds to phenobarbital. The following drugs are reported to have clinically significant interactions with phenobarbital:
A healthcare practitioner will usually order the test after the start of phenobarbital treatment and every few weeks thereafter. Testing may be more frequent any time the dose is adjusted up or down. Once a stable blood level of phenobarbital is achieved and is in the therapeutic range, then the healthcare practitioner will typically monitor levels at regular intervals to ensure that they are stable.
More frequent testing may be done if you begin taking or discontinue another medication that affects phenobarbital levels.
A healthcare provider might also order phenobarbital levels if you do not appear to be responding to the medication and continue to experience seizures.
Testing may be ordered when you experience side effects from phenobarbital. Most side effects are not serious and often go away with no further action. You should notify their healthcare provider if any of the following persist or become severe:
If any of the following symptoms are present, the healthcare provider should be notified immediately:
The therapeutic range for adults taking phenobarbital is 15-40 micrograms/milliliter (mcg/ml) (65-173 micromole/liter) for seizure treatment, and 5-15 micrograms/milliliter (mcg/ml) (22-65 micromole/liter) for sedative-hypnotic use. The therapeutic range for seizure treatment in children (younger than 5 years old) is narrower: 15-30 micrograms/milliliter (mcg/ml) (65-130 micromole/liter).
Within these ranges, most people will respond to the drug without displaying symptoms of toxicity. However, each person's response to the drug and side effects is individual. You may experience side effects even with blood levels at the low end of the therapeutic range or continue to have seizures at the upper end. As with other anti-epileptic drugs, your healthcare provider will work with you to find the dosage that works best.
Keep all appointments with your healthcare provider and the laboratory. Your healthcare practitioner will order certain lab tests to check your response to phenobarbital.
Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.
It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a healthcare provider or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.
You should take phenobarbital exactly as your healthcare provider has prescribed it. Do not decrease, increase the dose, or discontinue the medication on your own because doing so can increase your risk of having a seizure and can affect the levels of your other medications. Always consult your healthcare provider if you are having problems taking phenobarbital.
It may take several weeks to find the right dose, and even more time for your healthcare provider to know how well the medicine works to control your seizures. How long will this take depends on the conditions of each person. It may require 14-21 days to achieve the steady therapeutic blood level. Factors affecting dose optimization include how often you have seizures, what other medicines you may be taking, and how your body responds to phenobarbital.
In general, your levels will need to be monitored as long as you are taking the medication. Phenobarbital, like other anti-epileptic drugs, is usually taken every day (sometimes several times a day) for your lifetime. Exceptions to this may be adults who have outgrown their epileptic syndromes from childhood or people whose seizures are caused by a temporary condition and only need the medication for a limited time.
It might. Be sure to tell your healthcare providers the names of all prescription medicines, herbal or dietary supplements, vitamins, and over-the-counter medicines you take. Some of these may interfere with how phenobarbital works, lowering or raising the level in your blood. Phenobarbital may also affect how other medicines work.
Primidone is another medication that is used to control seizures. Phenobarbital is the major breakdown product (metabolite) of primidone that is also active in controlling seizures. To ensure that there is enough active drug in your blood to control your symptoms without causing toxicity, your healthcare provider may monitor phenobarbital when you are prescribed primidone.
Sources Used in Current Review
Current review performed by Yanhua Zhang, PhD, DNRCC-TC, FAACC, Scientific Director, Total Toxicology Labs.
September 15, 2018) MedlinePlus. Drugs Herbs and Supplements. Phenobarbital. Available online at https://medlineplus.gov/druginfo/meds/a682007.html. Accessed November 2019.
(Copyright © 2019) RxList. Phenobarbital. Available online at https://www.rxlist.com/phenobarbital-drug.htm#interactions. Accessed November 2019.
(January 3, 2014) Bentley, S. Phenobarbital Level. Medscape Reference. Available online at https://emedicine.medscape.com/article/2090284-overview. Accessed November 2019.
Sources Used in Previous Reviews
National Institutes of Health MedlinePlus. Phenobarbital. Available online at http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682007.html. Reviewed October 1, 2007. Accessed October 3, 2008.
NetdoctorUK.com. Phenobarbital. Available online at http://www.netdoctor.co.uk/medicines/10002060.html. Reviewed August 1, 2007. Accessed October 3, 2008.
Warner, A. et al. Standards of laboratory practice: Antiepileptic Drug Monitoring. Clinical Chemistry 1998; 44:1085–1095. Available online at http://www.clinchem.org/cgi/reprint/44/5/1085. Accessed October 4, 2008.
Kwan, P. and Brodie, M. Phenobarbital for the Treatment of Epilepsy in the 21st Century: A Critical Review. Epilepsia 2004; 9: 1141-1149. Available online at https://www3.interscience.wiley.com/cgi-bin/fulltext/118751051/HTMLSTART?CRETRY=1&SRETRY=0. Accessed October 4, 2008.
American Society of Health System Pharmacists. Phenobarbital (Systemic). Available online at http://www.ashp.org/mngrphs/essentials/a382855e.htm. Revised August 2007. Accessed October 5, 2008.
San Diego Reference Laboratory. Phenobarbital. Available online at http://www.sdrl.com/druglist/phenobarbital.html. Accessed October 7, 2008.
Burgess, C. ed. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 4th Edition, 2006. P. 2312.
Epilepsy Therapy Development Project. Children and Phenobarbital. Available online at http://professionals.epilepsy.com/medications/p_phenobarbital_children.html. Accessed October 5, 2008.
Emory School of Medicine, Department of Human Genetics. Seizures and Pregnancy. PDF available for download at http://www.genetics.emory.edu/pdf/Emory_Human_Genetics_Seizures_Pregnancy.PDF. Issued 2004. Accessed October 7, 2008.
UC San Diego Medical Center. Safety of Commonly Used Drugs in Nursing Mothers. Available online at http://health.ucsd.edu/specialties/pharmacy/resources/breastfeeding.asp. Reviewed April 2005. Accessed October 8, 2008.
Spencer, Jeanne P. et al. American Family Physician. Medications in the Breast Feeding Mother. Published July 1, 2001. Available online at http://www.aafp.org/afp/20010701/119.html. Accessed October 8, 2008.
Food and Drug Administration. Information for Healthcare Professionals: Suicidality and Antiepileptic Drugs. Available online at http://www.fda.gov/cder/drug/InfoSheets/HCP/antiepilepticsHCP.htm. Issued January 31, 2008. Accessed October 4, 2008.
Reinberg, Steve. FDA Advisers Don't Back 'Black Box' Warning for Epilepsy Drugs. The Washington Post. Available online at http://www.washingtonpost.com/wp-dyn/content/article/2008/07/10/AR2008071002527.html. Published July 10, 2008. Accessed October 7, 2008.
(September 27 2012) National Institutes of Health MedlinePlus. Phenobarbital. Available online at http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682007.html. Accessed October 2012.
(September 25, 2012) Ochoa J. Antiepileptic Drugs. Medscape Reference. Available online at http://emedicine.medscape.com/article/1187334-overview. Accessed October 2012.
(December 2, 2011) Cavasos J. Epilepsy and Seizures. Medscape Reference. Available online at http://emedicine.medscape.com/article/1184846-overview. Accessed October 2012.
(April 28, 2011) Mayo Clinic. Epilepsy Treatment and Drugs. Available online at http://www.mayoclinic.com/health/epilepsy/DS00342/DSECTION=treatments-and-drugs. Accessed October 2012.
Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. Burtis CA, Ashwood ER, Bruns DE, eds. 4th edition, St. Louis: Elsevier Saunders; 2006, Pp 1252-1253.
June 2015 review performed by Irene Shu, PhD, DABCC, Assistant Laboratory Director, USDTL.
(2015 July 1, Updated) Mayo Clinic. Barbiturate. Available online at http://www.mayoclinic.org/drugs-supplements/barbiturate-oral-route-parenteral-route-rectal-route/description/drg-20069290. Accessed on 7/13/2015.
Suzanne Bentley, MD (2014 January 3rd, Updated). Phenobarbital Level. Medscape. Available online at http://emedicine.medscape.com/article/2090284-overview. Accessed on 7/13/2015.
Baselt R.C. (© 2014). Disposition of Toxic Drugs and Chemicals in Man. 10th Edition: Biomedical Publications. Seal Beach, CA. Pp 1607-1609.
Levine B. I. (© 2010). Principles of Forensic Toxicology 3rd Edition: American Association for Clinical Chemistry, Inc. Washington, DC. Pp 215 – 220.